130 related articles for article (PubMed ID: 38318544)
21. The efficacy of metacognitive therapy on patients suffering from pure obsession.
Andouz Z; Dolatshahi B; Moshtagh N; Dadkhah A
Iran J Psychiatry; 2012; 7(1):11-21. PubMed ID: 23056112
[TBL] [Abstract][Full Text] [Related]
22. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
[TBL] [Abstract][Full Text] [Related]
23. L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.
Nematizadeh M; Ghorbanzadeh H; Moghaddam HS; Shalbafan M; Boroon M; Keshavarz-Akhlaghi AA; Akhondzadeh S
Psychiatry Clin Neurosci; 2023 Sep; 77(9):478-485. PubMed ID: 37169515
[TBL] [Abstract][Full Text] [Related]
24. An explorative study on metacognition in obsessive-compulsive disorder and panic disorder.
Cucchi M; Bottelli V; Cavadini D; Ricci L; Conca V; Ronchi P; Smeraldi E
Compr Psychiatry; 2012 Jul; 53(5):546-53. PubMed ID: 22018834
[TBL] [Abstract][Full Text] [Related]
25. Embitterment and metacognition in obsessive-compulsive disorder.
Mavrogiorgou P; Becker S; Lee-Grimm SI; Juckel G
BMC Psychiatry; 2023 Mar; 23(1):146. PubMed ID: 36890494
[TBL] [Abstract][Full Text] [Related]
26. Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial.
Shokrani M; Askari S; Eissazade N; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
BMC Psychiatry; 2023 Sep; 23(1):686. PubMed ID: 37735631
[TBL] [Abstract][Full Text] [Related]
27. The relationship between metacognitive beliefs and symptoms in eating disorders.
Georgantopoulos G; Konstantakopoulos G; Michopoulos I; Dikeos D; Gonidakis F
Psychiatriki; 2020; 31(3):225-235. PubMed ID: 33099463
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D levels in children and adolescents with obsessive compulsive disorder.
Yazici KU; Percinel Yazici I; Ustundag B
Nord J Psychiatry; 2018 Apr; 72(3):173-178. PubMed ID: 29168423
[TBL] [Abstract][Full Text] [Related]
29. Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Shannahoff-Khalsa D; Fernandes RY; Pereira CAB; March JS; Leckman JF; Golshan S; Vieira MSR; Polanczyk GV; Miguel EC; Shavitt RG
Front Psychiatry; 2019; 10():793. PubMed ID: 31780963
[No Abstract] [Full Text] [Related]
30. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition.
Zhang CC; Gong H; Zhang Y; Jin H; Yang Y; Li B; Li Y; Luo X; Liu W; Fang F; Li B; Sun B; Fletcher T; La Buissonnière-Ariza V; Goodman WK; Storch EA
Braz J Psychiatry; 2019; 41(6):494-498. PubMed ID: 30785537
[TBL] [Abstract][Full Text] [Related]
31. Social losses predict a faster onset and greater severity of obsessive-compulsive disorder.
Destrée L; Albertella L; Torres AR; Ferrão YA; Shavitt RG; Miguel EC; Fontenelle LF
J Psychiatr Res; 2020 Nov; 130():187-193. PubMed ID: 32828024
[TBL] [Abstract][Full Text] [Related]
32. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
[TBL] [Abstract][Full Text] [Related]
33. Validation of the Yale-Brown Obsessive-Compulsive Severity Scale in African Americans with obsessive-compulsive disorder.
Williams MT; Wetterneck CT; Thibodeau MA; Duque G
Psychiatry Res; 2013 Sep; 209(2):214-21. PubMed ID: 23664665
[TBL] [Abstract][Full Text] [Related]
34. The Impact of COVID-19 Pandemic on Obsession and Compulsion Symptoms in Saudi Arabia.
Alhujaili N; Alghamdi A; Abo Talib T; Alhaqbani M; Alfelali M; Alghamdi W
Cureus; 2021 Nov; 13(11):e20021. PubMed ID: 34987909
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of pure obsessive-compulsive disorder.
Torres AR; Shavitt RG; Torresan RC; Ferrão YA; Miguel EC; Fontenelle LF
Compr Psychiatry; 2013 Oct; 54(7):1042-52. PubMed ID: 23746710
[TBL] [Abstract][Full Text] [Related]
36. Dysfunctional metacognition across psychopathologies: A meta-analytic review.
Sun X; Zhu C; So SHW
Eur Psychiatry; 2017 Sep; 45():139-153. PubMed ID: 28763680
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated with Depression in Obsessive-Compulsive Disorder: A Cross-Sectional Study.
Altintaş E; Taşkintuna N
Noro Psikiyatr Ars; 2015 Dec; 52(4):346-353. PubMed ID: 28360738
[TBL] [Abstract][Full Text] [Related]
38. The Investigation of Transdiagnostic Role of Obsessive Beliefs: Comparison of Clinical Groups Diagnosed with Obsessive Compulsive Disorder, Anxiety Disorders and Depression with University Students.
Inozu M; Keser E; Erel S; Sari BA; Haciömeroğlu AB; Özmenler KN
Turk Psikiyatri Derg; 2022; 33(1):22-31. PubMed ID: 35343578
[TBL] [Abstract][Full Text] [Related]
39. Effects of the COVID-19 Pandemic on Obsessive-Compulsive Symptoms Among University Students: Prospective Cohort Survey Study.
Ji G; Wei W; Yue KC; Li H; Shi LJ; Ma JD; He CY; Zhou SS; Zhao Z; Lou T; Cheng J; Yang SC; Hu XZ
J Med Internet Res; 2020 Sep; 22(9):e21915. PubMed ID: 32931444
[TBL] [Abstract][Full Text] [Related]
40. A comparison of 'not just right experiences' in obsessive-compulsive disorder, anxiety and depressive disorders and non-clinical controls in China.
Yang L; Chen D; Zhang X; Huang F; Li Z; Yang X
Clin Psychol Psychother; 2023 Sep; ():. PubMed ID: 37749937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
